Deep Dive: Turkish Doctor Warns Unnecessary Aspirin Use Causes Hidden Gastrointestinal Bleeding

The warning from Dr. Öğr. Üyesi Özgür Kılıç underscores a growing public health concern in Turkey, where aspirin's widespread use for pain relief, cardiovascular prevention, and self-medication has led to undetected gastrointestinal complications. Aspirin (acetylsalicylic acid, a nonsteroidal anti-inflammatory drug commonly used for its blood-thinning properties) inhibits platelet function and irritates the gastric mucosa, potentially causing chronic low-level bleeding that manifests as fatigue rather than acute symptoms. This issue is particularly relevant in aging populations or those with undiagnosed conditions who turn to over-the-counter aspirin without medical guidance. In the context of Samsun, a Black Sea coastal city with a population reliant on accessible healthcare through public universities like OMÜ (Ondokuz Mayıs University, a leading institution for medical training in northern Turkey), such cases strain diagnostic resources. Endoscopy (a procedure using a flexible tube with a camera to examine the upper digestive tract) and colonoscopy (similar procedure for the lower intestine) are invasive and carry risks, yet are necessitated by aspirin's erosive effects. The doctor's observations reflect broader trends in pharmaceutical self-management, amplified by increasing availability of low-dose aspirin for heart health. Implications extend to healthcare policy and patient education in Turkey, where aspirin is inexpensive and heavily marketed. Unnecessary use not only burdens endoscopy units but delays diagnosis of other conditions mimicking anemia from bleeding. Stakeholders include primary care physicians, pharmacists, and regulatory bodies overseeing OTC drugs. Outlook suggests a need for targeted campaigns to promote aspirin only under supervision, potentially reducing test volumes and improving outcomes for at-risk groups like the elderly. Cross-border parallels exist in regions with similar self-medication cultures, such as Eastern Europe and the Middle East, where aspirin remains a staple. This Turkish perspective contributes to global discourse on balancing aspirin's benefits against risks, urging nuanced prescribing amid rising chronic disease prevalence.